Bringing the fundamentals into focus…
Back to Vertex Pharmaceuticals Incorporated
How Vertex Pharmaceuticals Incorporated stacks up
VRTX · against 454 other Healthcare companies listed in US-listed
Growth
58/ 100
Below the middle of the pack.
Ranked #255 of 455 · scores higher than 43% of peers
Bars: peers in each 10-point band of the growth score45 peers with a growth score of 50–59, including VRTX · Click a bar to see the companies
Why growth scores 58?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- faster revenue growth over three years: stronger than 62% of peers. 3-year revenue growth: 9.8% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 62% of peers. Revenue growth: 10.2% vs peer median 6.1%
- faster growth in earnings per share: stronger than 64% of peers. Earnings per share growth: 22.5% vs peer median 9.8%
Metric by metric
Position: dot = VRTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VRTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 10.2% | 11.0% | 49% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 22.5% | 21.2% | 52% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 9.8% | 11.0% | 47% | 33% |
Ranking by growth score
Top 5 and the companies ranked around VRTX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 255 | 50.2B USD | 58 | 49 | |
| 255 | 52.9B USD | 58 | 57 | |
| 255 | 5.0B USD | 58 | 60 | |
| 255 | 119.1B USD | 58 | 57 | |
| 255 | 134.5B USD | 58 | 70 | |
| 262 | 7.2B USD | 57 | 43 | |
| 262 | 11.6B USD | 57 | 56 | |
| 262 | 1.1B USD | 57 | 43 | |
| 262 | 302.7B USD | 57 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score